29
Active Trials
8
Phase 1
4
Phase 2
17
Phase 3
10
Therapeutic Areas
Immunology
6 active / 12 total
CNS
5 active / 76 total
ALS
2 active
1 Ph3
11 total since 2015
Multiple Sclerosis
1 active
1 Ph3
32 total since 2015
Alzheimer's Disease
1 active
12 total since 2015
Parkinson's Disease
1 active
7 total since 2015
Major Depression
0 active
10 total since 2015
Bipolar Disorder
0 active
1 total since 2015
Epilepsy
0 active
1 total since 2015
Schizophrenia
0 active
1 total since 2015
Neuropathy
0 active
1 total since 2015
Urology
4 active / 7 total
Rare Disease
2 active / 5 total
Cardiovascular
1 active / 11 total
Pain
0 active / 8 total
Renal
0 active / 2 total
Metabolic
0 active / 2 total
Sleep
0 active / 1 total
Respiratory
0 active / 1 total
Click an indication to see competitive landscape (all sponsors in that indication).
Data: ClinicalTrials.gov (2015+)